Ligand Pharmaceuticals (LGND) Research & Development (2010 - 2026)
Ligand Pharmaceuticals (LGND) posted Research & Development of $14.67 million for Q2 2026, up 123.4% from $6.57 million a year earlier and up 582.9% from the prior quarter.
Powered by 
Analysis
Ligand Pharmaceuticals (LGND) Research & Development (2010 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Research & Development at Ligand Pharmaceuticals was $41.35 million, down 38.1% year-over-year; for FY2025, it came in at $81.18 million, up 278.9% from FY2024.
- Annual Research & Development shows a five-year compound annual growth rate of 14.9% (FY2020 to FY2025).
- In prior years, Ligand Pharmaceuticals' Research & Development was $21.43 million in FY2024 (-12.7%), $24.54 million in FY2023 (-32.0%), $36.08 million in FY2022 (+12.4%) and $32.11 million in FY2021 (-20.7%).
- Quarterly Research & Development has run from a low of $2.15 million in Q1 2026 to a high of $50.09 million in Q1 2025 over five years.
- On a year-over-year basis, Research & Development increased in five of the last eight quarters, with growth averaging 127.8%.
- The strongest year-over-year quarter for Research & Development in the past five years was Q1 2025, with growth of 738.8%; the weakest was Q1 2026, with a decline of 95.7%.
- According to Business Quant data, Research & Development for the three prior quarters was $2.15 million (Q1 2026), $3.51 million (Q4 2025) and $21.02 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 3.65 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 2.34 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 9.74 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | -2.85 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | -4.05 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 1.87 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 1.76 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 2.81 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 993.80 Mn |
| 10 | Ligand Pharmaceuticals | 6.26 Bn | 2.72 Bn | - | 14.67 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 14.67 Mn |
| Mar 31, 2026 | 2.15 Mn |
| Dec 31, 2025 | 3.51 Mn |
| Sep 30, 2025 | 21.02 Mn |
| Jun 30, 2025 | 6.57 Mn |
| Mar 31, 2025 | 50.09 Mn |
| Dec 31, 2024 | 4.43 Mn |
| Sep 30, 2024 | 5.68 Mn |
| Jun 30, 2024 | 5.35 Mn |
| Mar 31, 2024 | 5.97 Mn |
| Dec 31, 2023 | 5.49 Mn |
| Sep 30, 2023 | 5.53 Mn |
| Jun 30, 2023 | 6.85 Mn |
| Mar 31, 2023 | 6.66 Mn |
| Dec 31, 2022 | 9.20 Mn |
| Sep 30, 2022 | 9.24 Mn |
| Jun 30, 2022 | 8.47 Mn |
| Mar 31, 2022 | 9.18 Mn |
| Dec 31, 2021 | 8.15 Mn |
| Sep 30, 2021 | 7.43 Mn |
API Access
Ligand Pharmaceuticals Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=LGND&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "LGND", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=LGND&period=max&api_key=YOUR_API_KEY");
const data = await res.json();